Company intelligence / Profile preview

NuCicer

Davis, California, United Statesnucicer.com ↗

Ownership: Private
Development stage: Other

Overview

NuCicer has developed chickpea varieties with up to 75% more protein than conventional types using advanced genomics and machine learning-driven plant breeding. Their products are positioned as sustainable, high-protein ingredients for the plant-based food industry. The company leverages a unique germplasm library with extensive wild chickpea biodiversity to improve agronomic traits and nutritional profiles. No clinical results apply as this is an agricultural/food tech firm.

Modalities: Plant breedingGenomics-guided breedingMolecular breeding
Industry: Agriculture & AgTech

Partnerships

Leaps by Bayer (lead investor/partner)Potential collaborations with UC Davis researchers

Beyond the preview

Go deeper on NuCicer.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NuCicer.

Explore the full profile